MedPath

Prevention of Ventilator Associated Pneumonia With Toothbrushing in Oral Care of Critically Ill Mechanically Ventilated Patients

Completed
Conditions
Ventilator Associated Pneumonia Prevention
Mechanical Ventilation
Critical Care
Toothbrushing
Oral Care
Registration Number
NCT02400294
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

Effect of toothbrushing in oral care of mechanically ventilated critically ill patients on prevention of ventilator associated pneumonia

Detailed Description

Prospective, before and after study in 5 Intensive Care Units (ICUs) of a university hospital.

The before period (control phase, 6 months): standard oral care 3 times a day in every consecutive intubated patients in the participating ICUs The interphase period (1 month): formal training of all the nurses, physicians and residents on the use of toothbrushing during oral care The after period: (study phase, 6 months): standard oral care with tooth brushing 3 times a day in every consecutive intubated patients in the participating ICUs

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2030
Inclusion Criteria
  • Adult patients
  • Intubated mechanically ventilated ICU patient
  • Platelets count >50G/L
Exclusion Criteria
  • Edentulous patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Nosocomial ventilator associated pneumoniaat Day-28

Presence of at least two signs (body fever greater than 38°C; leukocytosis greater than 12000/ml or leukopenia below 4000/ml, purulent pulmonary secretions) associated with the appearance of a new infiltrate or modification of an existing infiltrate on chest-X-ray. Confirmation by a lower respiratory tract sample using a quantitative culture with a predefined positive threshold. Hospital-acquired pneumonia was defined as a pneumonia that occurs at least 48 hours after admission, which was not incubating at time of admission (Am J Respir Crit Care Med 2005; 171, 388-416).

Secondary Outcome Measures
NameTimeMethod
Hospital mortalityat Day-90
ICU length of stayat Day-90
ICU mortalityat Day-90
Tracheobronchitisat Day-28

Association of at least two signs (fever above 38.0°C, Leucocytosis above 12000/ml or purulent pulmonary secretions) with isolation of bacteria in a lower respiratory tract sample without modification of chest-X-Ray.

Antibiotic free daysat Day-90

Trial Locations

Locations (1)

CHU Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath